RESPONSIVENESS OF THE SF-36 AND A CONDITION-SPECIFIC MEASURE OF HEALTH FOR PATIENTS WITH VARICOSE-VEINS

Citation
Am. Garratt et al., RESPONSIVENESS OF THE SF-36 AND A CONDITION-SPECIFIC MEASURE OF HEALTH FOR PATIENTS WITH VARICOSE-VEINS, Quality of life research, 5(2), 1996, pp. 223-234
Citations number
33
Categorie Soggetti
Public, Environmental & Occupation Heath",Nursing
Journal title
ISSN journal
09629343
Volume
5
Issue
2
Year of publication
1996
Pages
223 - 234
Database
ISI
SICI code
0962-9343(1996)5:2<223:ROTSAA>2.0.ZU;2-P
Abstract
Approaches to measuring patient perceptions of outcome for varicose ve ins were tested using a postal questionnaire incorporating a clinicall y derived specific measure of varicose veins severity and the SF-36 he alth survey. The questionnaire was administered to 373 patients with v aricose veins, 287 of whom had been referred to hospital for their var icose veins and 86 who had just consulted a general practitioner for t he condition. The response rate exceeded 75%. Test-retest reliability was assessed by mailing patients a similar questionnaire at two weeks. The validity of the two instruments was assessed by comparing patient scores to general practitioner ratings of symptom severity and compli cations associated with varicose veins. Standardized response means (m ean change in scores divided by the standard deviation of the change i n scores) were used to quantify and compare the responsiveness of the two measures. Levels of test-retest reliability, as assessed by the in traclass correlation coefficient, were acceptable and the instruments appear to have good levels of validity. Patients who were or were not admitted to hospital for surgery on their veins had significant improv ements in perceived health status on both the specific measure and the SF-36. The specific measure was the most responsive to changes in hea lth status for both patients who were admitted to hospital for surgery and those receiving alternative forms of management. These two approa ches might be suitable as part of a package of outcome measures for us e in clinical trials to assess the effectiveness of different interven tions for varicose veins.